marketinsights

Worldwide Market Reports added Latest Research Report titled “Powder Coatings Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Powder Coatings Market was valued at US$ 9,130.4 Million in 2016, according to a new report published by Coherent Market Insights. The increasing use of powder coatings in various end-use industries such as appliances, automotive, furniture, architecture, and industrial will enhance the market growth in the forecast period. The solvent free content of these coatings results in negligible or low volatile organic compounds (VOC) emissions, which in turn makes these products environment friendly and hence, fuel demand for these coatings globally.
The global powder coatings market has witnessed significant growth in the last five years, owing to its added advantage over liquid coatings and low VOC emissions that helps end-use industries ensure regulatory compliance. Powder coatings helps in maintaining the outer appearance of the substrate on which they are applied and therefore, are extensively used by furniture manufacturers. These coatings are mainly applied on metal substrates as it helps in preventing scratches and provides better gloss appearance to the product as compared to other coatings.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187585

Thermoset resin is the largest resin type segment that accounts for over 90% market share in the global powder coatings market. These resins are mostly preferred as they help in preventing shock and corrosion to industrial equipment, various appliances, and automobile parts and thereby, helps increase the lifespan of the product. Epoxy polyester hybrid resin segment is projected to witness the fastest growth during the forecast period. These resins are most suitable in heavy duty equipment, appliances, electrical enclosures, and agriculture equipment. Polyesters is expected to be the largest sub-segment in thermoset resin segment during the forecast period. These resins are highly applied in outdoor furniture and automotive parts manufacturing due to its superior performance in sunlight.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187585

Key takeaways of the market:
• Asia-Pacific is projected to be the largest region in global powder coatings market. It accounted for around 42% of overall powder coatings market revenue in 2016. The market in this region is expected to be primarily driven by rampant growth of end-use industries in China, India, and ASEAN countries. The growing construction, and automotive end-use industries, rising urbanization, growing demand for fully furnished homes are some of the key drivers for the growth of powder coatings in the Asia-Pacific region.
• The market in Latin America is expected to register a significant growth rate over the forecast period. Rise in discretionary income along with increasing automotive sales, and construction activities are expected to create lucrative growth opportunities for the players in this region.
• Automotive industry is one of the key industries for the use of powder coatings. A strong automobile sales in Asia-Pacific and Europe is expected to enhance the growth of powder coatings in the forecast period. The automotive applications such as rims, door handles, and under-the-hood components are the key automotive application for the use of powder coatings. In 2013, global automobile production was around 84 million units and has since registered 10% growth every year. Furthermore, growing sales of appliances for domestic and commercial applications such as washing machines, microwave ovens, air conditioner, freezer cabinets are also fueling growth of the market.
• PPG industries, AkzoNobel, Sherwin Williams, BASF, Axalta Group, Nippon Paints, Jotun A/S, Kansai Paint Co., Ltd, E.I. DuPont and The Valspar Corporation are few of the key players in global powder coatings market.
• There are various organic, and inorganic growth strategies which are being followed by the leading market players in the market. Technological advancement is leading to the key innovation in the new product launches. Companies are also investing in expansions, mergers & acquisitions, and joint ventures in the market. For instance, PPG Industries launched a new cross-link polymer technology, which is introduced through ENVIROCRON HTE powder coatings. This product maximizes first pass transfer-efficiency rates for difficult-to-coat applications and provide faster built rates than traditional polyester coatings. Commercialization of the same is expected to scale the revenue over the forecast period.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Bone Glue Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Bone Glue Market was valued at US$ 1,648.3 million in 2015 and is projected to expand at a CAGR of 6.3% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Growing incidence of fractures and rapidly aging population are expected to be major factors driving growth of the global bone glue market over the foreseeable future.
Each year, an estimated 1.5 million people suffer from bone fracture, which leads to bone diseases. Fractures are the most common musculoskeletal medical condition, which accounts for a high number of hospitalization cases. Nearly one-third of bone disorder patients are admitted in hospitals or private day care centers. Thanks to the use of certain advanced bone glue products that are highly effective in treating minor fractures, a substantial number of people who suffer from fractures do not require any hospitalization.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187581

Bone density decreases with age, often leading to bone disorders among people over 60 years of age. According to WHO, bones become especially fragile in elderly women. Approximately, 1 in 4 women, i.e. around 24% of women aged 50 or older suffer from falls each year, as compared to nearly half of women aged 85 years and above. In many instances most of the falls lead to fracture, out of which 35-40% of bone fractures are healed or joined with the use of bone glue.
Musculoskeletal is a medical condition, which increases burden on an individual and healthcare system. Social care plays a pivotal role in ensuring effective healing in developed and under developed nations alike. Medical conditions under musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, osteoporosis, and low back pain account for a significant portion of the global healthcare burden. Osteoarthritis is characterized by cartilage joint damage which leads to severe pain and mobility, mainly in the knees and hip joints. According to WHO and United Nations, osteoarthritis affects 9.6% of males and 18% of females over 60 years and above. Increase in life expectancy and rapidly aging population are the major factors fueling incidence rate of osteoarthritis. It is projected to be the fourth largest cause of disability by 2020. Various joint replacement surgeries are conducted each year helping people overcome pain due to rheumatoid arthritis. Rheumatoid arthritis causes inflammation of the joints and usually affects multiple joints, affecting 0.3-1.0% of global population and high prevalence among women in developed regions. This creates highly lucrative growth opportunities for players in the global bone glue market.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187581

Key takeaways of the bone glue market:
• The global bone glue market is expected to expand at a CAGR of 6.3% during the forecast period (2016-2024) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa
• The natural bone glue dominates the market in the product segment, as it is the easy affordable product and this product is used for multiple fractures and tissue damage
• Arthroplasty and spinal Injuries are the major therapeutic application of bone glue market, as these therapeutic applications are more in number when compared to other bone disorders where bone glue is required
• Some of the major players involved in global bone glue market are Cryolife, Luna Innovations Incorporated, Johnson and Johnson, Cohera Medical Inc., Tissuemed Ltd., Integra Lifesciences Corporation, Baxter International Inc., B.Braun Melsungen AG, DENTSPLY SIRONA Inc., Chemence Medical Inc., and C.R. Bard Inc.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Malaria Vaccines Market is pegged to be valued at US$ 8.5 million in 2018 and is projected to expand at a CAGR of 102.8% during the forecast period (2018-2024), as highlighted in a new report published by Coherent Market Insights. Rise in demand for vaccines for important indications on the backdrop of increasing focus on biological preparations is expected to be a major factor driving growth of the global malaria vaccines market over the foreseeable future.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187577

According to World Health Organization (WHO) malaria fact sheet and World Bank estimates, over 40% of the global population is at risk of malaria. World Health Organization (WHO), there were around 214 million malaria cases reported in 2015, leading to 438,000 deaths worldwide. Over 70% of these deaths were among children under 5 years of age. Sub-Saharan Africa accounts for the highest share of global malaria burden, with around 89% of malaria cases and 91% of malarial deaths in 2015. Such high impact of this life-threatening disease is influencing governments across various countries, companies, investors, and non-profit organizations to contribute towards curbing spreading of this disease. Since the problem of malaria is burdening many of the emerging and under developed regions such as in Africa and Asia Pacific, various initiatives have been implemented in these regions to drive down high costs of the vaccine in development. For instance, in 2016, GSK announced plans to develop vaccines at a mere profit margin of 5% of the cost of the vaccine. Governments across most regions are actively involved in programs aimed at eliminating malaria. For instance, WHO had mobilized funding for pilot program in first phase between 2017 and 2020 by the global fund to fight against malaria and other disease such as AIDS and tuberculosis prevalent worldwide.
Shift from pharmaceutical oral dosage forms to parenteral dosage forms is expected boost the malaria vaccines market globally. The emerging economies are undergoing a wave of various healthcare reforms. Healthcare treatment regimens are becoming more reliable for the growth of the global market, with various initiatives in place to eradicate the menace of malaria. In 2016, in India, the National Framework for Malaria Elimination (NFME), was launched to eliminate the problem in the country. This program was based on the Framework by the National Vector Borne Disease Control Program (NVBDCP) of the Ministry of Health and Family Welfare. According to NFME, in 2012, the total economic burden of malaria in India was around US$ 1,940 Mn, with 75% from lost earnings and 25% from treatment costs borne by households.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187577

According to World Malaria Report 2015, India accounts for around 70% of the total malaria incidence rate in the South-East Asia. In 2014, the incidence rate of malaria in the country was around 0.89 per 1,000 person at risk per year. Around 1.1 Mn cases were reported, which lead to 562 deaths in India in 2014.
Key takeaways of the malaria vaccines market:
• The global malaria vaccines market is expected to expand at a CAGR of 102.8% during the forecast period (2016-2024) as there exists a large unrealized market especially in Africa, Asia Pacific, Latin America and Middle East
• The Pre-Erythrocytic Vaccine dominates the market in the vaccines type segment, as it is used to prevent the infection completely, while blood-stage vaccines aim to reduce or eliminate the parasite load once a person is infected
• Plasmodium Falciparum is the major agent segment of malaria vaccines market, as Plasmodium falciparum infection are induced by the asexual stages of the parasite that develop inside red blood cells, making it one of most severe forms of malaria among various types of parasites causing malaria
• Some of the major players involved in global malaria vaccines market are GlaxoSmithKline plc, Sanaria Inc, Nobelpharma Co., Ltd., Sumaya Biotech and GenVec, Inc.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Hearing Protection Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.

The Global Hearing Protection Devices Market was valued at US$ 908.3 million in 2015 and is projected to expand at a CAGR of 10.8% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights.
Increasing implementation of safety guidelines, increasing employment in construction sector, growing demand for next-generation hearing protector devices in armed force and cumulative expansion and development activities across the world are chief aspects which lead to augmented growth of the global hearing protection devices market. Also, low price earplugs marketed by local developers are likely to boost adoption in price sensitive emerging economies, in turn fueling growth of the hearing protection devices market. Lack of cognizance and hampered hearing when using these devices are factors projected to hinder growth of the global hearing protection devices market. Some of the major trends in the hearing protection devices market comprise increasing inclination of end users towards custom-tailored hearing protection devices, rise in merger and acquisitions agreements between manufacturing companies, technology shift towards ear plugs with acoustic filters, and increasing demand for uniform attenuation ear plugs

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187573

The global hearing protection devices market is considered to influence the labor and employee safety initiatives implemented by national government bodies and private labor safety related agencies in various industrial sectors such as manufacturing and construction. High-tech advancements to reduce active noise and aid noise suppression have led to impressive growth of the global market in the recent past. A latest development permits speech augmentation technology to be combined with noise clampdown technology.
The strengthened events related to industrial and construction and lightning industrial development in emerging economies may lay a substantial groundwork for growth of the Asia Pacific market progression. North America is projected to retain its dominance as the largest market for hearing protection devices over the following decade. This is mainly attributed to copious disposable income, pervading awareness about noise pollution, and rampant industrial development in the region. Lack of cognizance about the present products or devices that help prevent impaired hearing could inhibit growth of the hearing protection devices market, especially in low income countries. However, increasing implementation of safety standards in the region would pave way for market growth over the near future. Apart from Asia Pacific, increasing industrial and construction activities in Middle East and Africa create lucrative growth opportunities for market players.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187573

Key takeaways of the hearing protection devices market:
• The global hearing protection devices market is expected to expand at a CAGR of 10.8% during the forecast period (2016-2024) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa
• The ear plug dominates the market in the product segment as it is the easy affordable product developed and focused by mobile health device manufacturers
• Different protectors such as aural inserts and circum-aural protectors are expected to gain traction with growing awareness and increasing application areas
• Mining and construction are the major end users in the hearing protection devices market, as these organizations are human resource intensive sectors
• Some of the major players involved in global hearing protection include 3M, Starkey Laboratories India Pvt. Ltd, Honeywell International Inc, Hellberg Safety Ab, Amplifon., Dynamic Ear Company, Centurion Safety Products Ltd., Sonomax Technologies Inc, Siemens Healthcare GmbH, ADCO Hearing Products Inc, and Elvex Corporation and Moldex-Metric Inc.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Tuberculosis Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.

The Global Tuberculosis Drugs Market was valued at US$ 1,389.3 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Growing prevalence of tuberculosis and increasing tobacco smoking is expected to drive growth of the global tuberculosis drugs market.
Drug shortage to treat tuberculosis is a major challenge to effective healthcare in the U.S., with the shortage of drug number tripling from 2007 to 2012. This factor seems to be troublesome and represents a public health threat. U.S. Government Accountability Office reported that there is 16% shortage of anti-infective drugs, including that for tuberculosis. Various healthcare agencies have organized TB awareness campaigns across the U.S. and had difficulty in accessing medicines and products to diagnose the disease and this is due to shortage, supply disruptions, and high costs of the products. The success story of India drugs market is timely and adequate supply of drugs, though it has been hit the hardest due to poor government policies and tough procurement procedures.
Multidrug-resistant tuberculosis (MDR-TB) is a rising health issue globally. The level and encumbrance of multidrug-resistant tuberculosis differs significantly by region and country. Across the globe, around 3% of all new cases of patients diagnosed with TB have multidrug-resistant tuberculosis and the percentage is more in patients who had already accepted anti-tuberculosis treatment replicating the failure of programs intended to ensure complete cure of patients with tuberculosis. To manage multidrug-resistant tuberculosis is a huge task and that should be accepted by experienced clinicians at centers where there are well-equipped process and with reliable laboratory services and also by implementing the DOTS-Plus strategy.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187569

Asia and Africa provide largely untapped growth avenues for players in the global tuberculosis drugs market
The global spread of tuberculosis cases is tilted predominantly toward low-income and emerging economies countries. The highest prevalence of tuberculosis cases are in Asia, which includes China, India, Bangladesh, Indonesia, and Pakistan contributing 50% of the global tuberculosis burden. Africa is one of the most tuberculosis infested regions globally and unambiguously the sub-Saharan Africa has the highest rate of tuberculosis incidence, with 83 and 290 patients per 100,000, respectively. Tuberculosis cases occur highly between the age group of 15 to 49 year. According to World Health Organization, tuberculosis is projected to yield an annual economic toll of US$12 billion from the income of poor people. Many literature studies explain that the average work time lost by an individual after getting injected by tuberculosis bacteria is around 3-4 months, which further result in a mean lost potential earnings of 20%-30% of the annual household income and over deaths caused by premature tuberculosis deaths the loss of income is ~15 years, estimated by WHO. Thus, the global tuberculosis drugs market is expected to witness steady growth in the foreseeable future.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187569

Key takeaways of the market:
• The global tuberculosis drugs market is expected to expand at a CAGR of 5.9% during the forecast period (2016-2024) as there still exists a major unrealized market, especially in Asia Pacific, Latin America, Middle East and Africa
• The first line drugs therapy dominates the tuberculosis drugs market in the therapy type segment as it is the primary and basic tuberculosis drugs used to treat the patients who are effected with the tuberculosis for the first time
• Incidence of tuberculosis is high in Africa and Asia
• There are 4 new treatment drug in clinical trials. Approval of a new drug could be a major breakthrough in the global tuberculosis drugs market.
• Some of the major players involved in global tuberculosis drugs market are Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc, Cadila Pharmaceuticals, Novartis AG, Alkem Laboratories Ltd, and Cipla Ltd.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Gynecological Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Gynecological Devices Market was valued at US$ 2,667.8 million in 2015 and is projected to expand at a CAGR of 6.3% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Increasing incidence of gynecological disorders is projected to favor the growth for gynecological devices market in the near future.
Around 10% of the global female population is affected by endometriosis according to the estimates by Endmoetriosis UK (2016). Risk of gynecological disorders increases with age. According to the World Bank, female population aged 65 years and above increased exponentially from 6.8% in 2010 to 8.2% in 2015. Furthermore, changing lifestyle habits and risk of infection is expected to result in high incidence of gynecological disorders. The outlook for the gynecological devices market is therefore bright in the foreseeable future.
Safety is one of the major concerns of healthcare practitioners using gynecological devices. Bayer's Essure is an intra-uterine device (IUD) that has been linked with skin rashes and pelvic pain in women (in the U.S.) who have inserted it as a permanent contraceptive solution. This has led women to remove the Essure through surgery. The U.S. FDA has called for a black box warning for the device. Furthermore, the FDA has also asked manufacturers of power morcellators to mention a warning that the product ‘has not been proved to reduce the risk of spreading cancer'. Power morcellators are used to dissect and remove uterus or uterine fibroids through small incisions.

Request for Sample Copy of Research Report:https://www.worldwidemarketreports.com/sample/187565

However, these devices are reported to cause uterine cancer, which remain undetected owing to lack of awareness.
Post-surgical complications are among the most frequent complications in abdominopelvic surgery. Endometriosis and infection in pelvic region can stimulate the formation of adhesions, which may lead to discomfort, chronic pain and infertility. Actamax Surgical Materials LLC (subsidiary of DSM Biomedical), submitted an Investigational Device Exemption (IDE) to the U.S. FDA in February 2017 for its Actamax adhesion barrier to be utilized in in gynecological laparoscopic surgery. Such innovative solutions for the existing concerns on the gynecological surgeries would favor the growth of gynecological devices market globally.
Get Best Discount on Research Report:https://www.worldwidemarketreports.com/discount/187565

Being a very intimate category of devices, safety is therefore the priority for users. Manufacturers need to gather enough evidences of safety and efficacy to avoid post-marketing recalls and regulatory hurdles. Specialized speculums, curettes, and forceps ease the surgical procedures. Demand for gynecological chairs is expected to grow rapidly during the forecast period as hospitals upgrade their infrastructure, especially in emerging economies such as India, China, and Brazil.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Artificial Pancreas Device System Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Artificial Pancreas Device System (APDS) Market was valued at US$ 64.0 million in 2015 and is projected to expand at a CAGR of 18.6 % during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Growing demand for continuous diabetes monitoring and minimally invasive drug delivery system is expected to fuel growth of the artificial pancreas device system (APDS) market.
Type 1 diabetes patients require multiple doses of insulin through the day in order to manage their diabetes condition. Considering the current lack of feasible alternative solution to manage type 1 diabetes apart from administering insulin, an artificial pancreas that offers convenience with continuous management of glucose level in the body is the next best solution. An artificial pancreas system works 24 hours to automatically monitor and administer insulin in controlled amounts as per variations in glucose levels in the body. Medtronic’s MiniMed 620G and 640G were the first such devices launched in the global artificial pancreas device system (APDS) market in 2014 and 2015, respectively. Artificial pancreas system would ease the life of type 1 diabetic patients by eliminating the need for regular check on glucose level and administering insulin using injectors or pens.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187561

Various companies are researching and developing artificial pancreas systems that are expected to enter the global artificial pancreas device system (APDS) market in the not-too-distant future. Bigfoot Medical, Tandem Diabetes Care, Inc., and Beta Bionics are conducting clinical trials on their artificial pancreas systems. The products are expected to be launched before 2020 and would stimulate market growth at an exponential rate. However, to no one’s notice there is another artificial pancreas system besides Medtronic’s 640G, Medtrum’s P6 Easy Touch Disposable Pump already marketed in Europe. This is a semi-closed loop artificial pancreas that has 9% mean absolute relative difference (MARD), better than Freestyle Libre (11.4% MARD)
The closed loop system is a life changing device for type 1 diabetes patients giving them freedom to live an uninterrupted life. Though the FDA has approved a hybrid model of an artificial pancreas, wherein the patient needs to adjust insulin intake during mealtime, an automated system would be a breakthrough innovation in the global artificial pancreas device system (APDS) market. Moreover, studies for bi-hormonal control system are underway that would enable controlling both hypoglycemic and hyperglycemic conditions. A bi-hormonal control system consists of dual-chamber pump, one containing insulin and the other containing its counteracting hormone, glucagon.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187561

According to the industry and Center for Diseases Control and Prevention (CDC) estimates, type 1 diabetes population accounts for nearly 5% of the total diabetic population. According to Juvenile Diabetes Research Foundation (JDRF), there were around 1.5 million type 1 diabetics worldwide in 2015. The CDC estimates that more than 13,000 young people are diagnosed with type 1 diabetes every year in the U.S. Increase in the population base along with the quest for developing an innovative diabetes monitoring and management therapy is projected to drive growth of the global artificial pancreas device system (APDS) market.
Key takeaways of the market:
• The global artificial pancreas device system (APDS) market is characterized by collaborations between players in order allow for early commercial launch of their products. Moreover, a number of products are in development with different artificial pancreas system technologies. However, an automated hybrid closed-loop system would dominate the market owing to better features offering convenience and minimal monitoring and work for the patient to administer insulin.
• The global artificial pancreas device system (APDS) market is expected to experience very high growth during the forecast period with expected launch of new systems every year till 2020, after which it is expected to register sustained stable growth
• The market for control to target (CTT) artificial pancreas system is expected to grow rapidly with the launch of MiniMed 670G, which will eliminate the need for setting insulin dose by the patient at meal times
• Type 2 diabetic patents hold more than 95% share in the global artificial pancreas device system (APDS) market
• Furthermore, being a novel device, the market for artificial pancreas system is estimated to be high and rapidly growing in North America and Europe as these are the major target markets for market players. Launch of artificial pancreas system later in emerging economies is expected to stimulate growth in Asia Pacific and Latin America artificial pancreas device system (APDS) markets towards the latter half of the forecast period.
• Medtronic is expected to account for a major share of the global artificial pancreas device system (APDS) market, with a range of products such as MiniMed 530G, 640G, and 670G expected to be launched during the forecast period.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Veterinary Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA), In the European Union (EU), over 320,000 fatalities are reported each year due to food-borne zoonotic diseases.
Zoonoses are infections that directly infect humans or are indirectly transmitted to humans through animals by transmission of micro-organisms such as such as bacteria and their toxins, viruses and parasites. This can be caused due to consumption of contaminated food in contact with infected animals or contaminated meat products. Severity of such diseases varies from mild symptoms to life-threatening conditions. Most such micro-organisms are found in the intestines of healthy food-producing animals. The above concern is one of the major factors projected to propel growth of the market for veterinary vaccines over the forecast period. Furthermore, livestock animals serve as a major source of primary and secondary food products. Rise in population of livestock animals is expected to fuel demand for veterinary vaccines in the near future. Veterinary vaccines promotes better growth of animals. According to WHO, in 2015, children under five years of age accounted for one third of all deaths due to foodborne diseases.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187557

Breakout of zoonotic diseases are dependent on various factors such as environmental changes, demographics related to human and animals, pathogen changes and farming practice modifications. According to Maine Center for Disease Control & Prevention, in 2013, around 75% diseases of animal origin affecting humans were infectious diseases. As animals are the closest companions to humans and also serve as sources of various products such as meat and milk, care should be given according to the severity of the disease from which they can be affected. The specificity of the vaccines is the most important factor that is responsible for the growth in demand for the veterinary vaccines that can be used as prophylaxis. According to clinical microbiology paper published in 2007, veterinary vaccines comprise around 25%of the animal health products globally. Growth for veterinary vaccines industry has grown consistently supported by various factors such as new technological advancements and introduction of novel vaccine development methods for cost effective products, which further favors the rise in availability and adoption rate for the veterinary vaccines globally. Also, drug resistance to existing pathogens and new diseases is also prompting focus on new drug discoveries.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187557

According to (American Veterinary Medical Association) JAVMA News in 2017, there have been various acquisitions and mergers in veterinary vaccines market in the recent past. However, 85 to 95% of veterinary hospitals in the U.S. are owned independently. Mars Incorporated—a company involved in manufacturing of Petcare, Chocolate, Wrigley, Food and Drinks—is to acquire VCA Inc. - a pet health care services provider in the U.S. and Canada that delivers through nearly around 800 small veterinary hospitals - in total value of around US$ 9.1 billion . Furthermore, in recent years a trend of consolidation has been observed in the industry, as companies are experiencing focusing on leveraging potential through economies of improved business practices. Furthermore, there are various other factors responsible for significant growth in the veterinary vaccines market such as rise in swine population globally and increasing the reach for swine influenza virus globally is projected to favor the market for veterinary vaccines market over the forecast period.
Key takeaways of the market:
• The global veterinary vaccines market is expected to expand at a CAGR of 5.9% during the forecast period (2016-2024). Rise in pet vaccination awareness among the population globally is expected to favor the market for veterinary vaccines market over the forecast period.
• The live attenuated vaccines segment in the global veterinary vaccines market was estimated to be the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. Rise in demand for white meat in North America and Europe is expected to fuel the market to high growth over the forecast period
• In terms of animal type, the livestock type sub-segment is expected to expand at a significant CAGR of 5.6% during the forecast period owing to rise in population of livestock animal and the human dependency on the cattle for primary as well as secondary products
• The global veterinary vaccines market is characterized by strategic research and development and advancements in the technology of vaccines production. Also, the rise in adoption for poultry business globally is expected to favor the market for veterinary vaccines market.
• Some of the major players are Zoetis Inc. Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health, Elanco Animal Health, Ceva Animal Health, Heska Corporation, Virbac Inc., and Indian Immunological Ltd.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Defibrillators Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Defibrillators Market was valued at US$ 11.8 million in 2015 and is projected to expand at a CAGR of 6.0% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Rise in number of deaths related to cardiovascular on the backdrop of rise in prevalence of sudden cardiac arrest (SCA) among all the cardiovascular disorders is expected to be a major factor to support the defibrillators market over the forecast period.
In 2015, the U.S. FDA approved wearable defibrillator for children at risk of sudden cardiac arrest. According to Sudden Cardiac Arrest Foundation, in the state of Minnesota from 1993 to 2012, the incidence for the high school athletes suffered from cardiac death was .24 per 100,000. According to American Heart Association, in 2011, around 326,200 people in the U.S. experienced cardiac arrests at home or at workplace. Only around 10% among them were successfully revived by emergency medical services. Companies are focused towards product advancement regarding the lead time of device replacement. According to the U.S. FDA there have been incidents reported in the past, wherein the patient is unable to get the three months lead time for battery replacement. St. Jude Medical has reported that in certain cases, the entire battery can get drained within a day just after an elective replacement indicator (ERI), which can prove to be fatal.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187553

Companies are inclined towards developing latest technologies that can be used for homecare settings as well as for other end users such as hospitals and emergency medical services. In 2013, Philips introduced three new products namely HeartStart FRx, HeartStart HS1 Home, and HeartStart HS1 OnSite. These automated external defibrillators are used for cardiac arrhythmia management. The devices are pre-installed in first-aid carrying case, along with battery and pads that are easy to use during a medical emergency.
Major players are focused towards improving quality of the device, which would have a longer life and better performance. This highly consolidated market is characterized by extensive R&D activities culminating in development of advanced devices. This is mainly attributed to major players accounting for well over 50% share of the market.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187553

The market for implantable cardioverter defibrillator is expected to grow significantly over the forecast period. For instance, Medtronic's Attain Performa Quadripolar Lead and VivaQuad XT CRT-D system are new advanced products. The introduction of quadripolar lead devices is the promising advancement in the field of defibrillators, which in turn would allow more programming operations in pacing and overcoming other issues such as cardiac resynchronization therapy defibrillator (CRT-D). One of the major factors favoring growth of the defibrillators market is rise in consumption of tobacco and increasing number of smokers. According to W.H.O, in 2015, over 1.1 billion people smoked tobacco, with low- and middle-income countries accounting for around 80% share. Thus, these regions are highly lucrative, yet largely untapped markets, which would provide significant growth potential in the near future.
Key takeaways of the market:
• The global defibrillators market is expected to expand at a CAGR of 6.0% during the forecast period (2016-2024). According to W.H.O, 17.5 million people die each year from cardiovascular disease, an estimated 31% of all deaths worldwide, which in turn is expected to favor the growth of defibrillators market in the near future
• The single chamber implantable cardioverter defibrillator segment in the global defibrillators market was estimated to be the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. This is owing to high adoption rate for implantable devices. According to W.H.O, there were around 350,000 devices remain actively implanted globally in 2015.
• In terms of product type, the wearable cardioverter segment is expected to expand at a significant CAGR of 7.5% during the forecast period. This is expected to support the market on the backdrop of increase in global wearable device market due to the cost-effectiveness and ease in use of the devices.
• The global defibrillators market is characterized by strategic research and development and advancements in the devices, for instance, the Medtronic EV-ICD System, which currently in process of development and not out in the market yet is a novel advancement in the ICD therapy. The company claims that the extravascular placement of the leads and wires is expected to provide same benefits as the implantable devices.
• Some of the major players are Medtronic, St. Jude Medical, Koninklijke Philips N.V., Schiller, Cardioline SpA, Metrax GmbH (Primedic), Inovytec, Mindray DS USA, Inc., Medical Information Technology, Inc. and Bexen Cardio.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Vocal Biomarkers Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017-2028).
Mental and physical conditions such as anxiety and Parkinson's disease can make one slur his/her words, speak in a more nasal tone, and elongate sounds. Various companies involved in sales activities across industries and call centers deploy voice analysis systems to understand the temperament of the respondent. Cogito Corporation's voice analysis software is used by Humana, Inc. Blue Cross Blue Shield Associational and Smartmedical Corporation's Empath voice-based technology has been used by NTT Docomo, and Philips for emotional analytic and characterizing respondent's mood.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187549

Beyond Verbal, Inc., Cogito Corporation, IBM Corporation, and Sonde Health are involved in extensive R&D to establish a link between vocal biomarkers and disease condition(s). Depression is a very common disorder globally, with approximately 350 million people suffering from it (WHO, 2016). Successful identification of early signs of depression using a vocal biomarker system is anticipated to significantly help physicians to recommend specific preventive measures to the patient.
Free mobile applications such as Moodies and Empath (by Beyond Verbal, Inc.) offer features that analyze emotional state of an individual, enabling users to identify their mood during their most recent phone conversation. Health insurers such as Humana, Inc., Blue Cross Blue Shield Association, and Aetna, Inc. are leveraging vocal biomarkers to detect stress and depression in callers. The U.S. Department of Veteran Affairs deploys Cogito software to detect signs of post-traumatic stress disorder (PTSD) among soldiers. Realizing the robust future revenue potential from emotional analytics, leaders across the globe (companies and universities) are conducting research in order to capitalize upon the various health benefits offered by speech and voice technology. In November 2016, Mayo Clinic released the outcome of its study on vocal biomarkers which established a correlation between certain voice features and the likelihood of a coronary artery disease.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187549

Strategic collaborations among universities and existing players in order to decrease turnaround time for commercialization of the products is the recent trend observed in this industry. In June 2016, Sonde Health in-licensed the voice-based technology platform from the Massachusetts Institute of Technology Lincoln Laboratory. This technology has been developed for effective diagnosis and monitoring of mental and physical health conditions. The U.S. army collaborated with the Massachusetts Institute of Technology Lincoln Laboratory (MIT LL) in 2016 to develop an algorithm to identify vocal biomarkers that can diagnose traumatic brain injury.
Smartmedical Corp. (Japan) and Planet Healers (India) have commercialized a voice-based platform that can diagnose health conditions based on the voice of the user. While, Smartmedical's Empath is majorly used in analyzing mood, Planet Healer's ‘Voice Analysis' technology platform is intended for the diagnosis of user's health condition. Such products are expected to pave way for extensive application of vocal biomarkers across various industries. Moreover, use of vocal biomarkers to diagnose health conditions in children can prove to be a high potential application area in not so distant future.
Key takeaways of the market:
• The global vocal biomarkers market is classified on the basis of applications and end users. It provides analysis and future market potential across major geographies.
• Revenue contribution of depression and anxiety therapeutic application segment is expected to remain high throughout the forecast period. This is mainly attributed to high efficacy of the technology in identifying temper, happiness, sadness, depression, and anxiety, among other emotions of the subject.
• Mayo Clinic has introduced application of vocal biomarkers for coronary artery disease (CAD). This is analyzed to propel the use of vocal biomarker technology for diagnosis of CAD in the near future.
• Commercially, various military bodies are using this technology to detect/diagnose presence of any brain injury or depression among the team members
• Vocal biomarkers are expected to find increase in adoption among physicians; therefore hospitals end-use segment is projected to expand at a CAGR of 101.2% during the forecast period. The growth would be primarily attributed to its application for diagnosing Parkinson's disease, cognitive impairment, and respiratory disorders in the near future.
• Majority of users of this technology are currently based in developed economies such as the U.S., Canada, Japan, Germany, and the U.K. Adoption of Planet Healer's voice-based diagnosis technology platform is projected to witness positive traction for diagnosis of mental health condition in Asia Pacific region during the forecast period.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Custom LASIK Surgery Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Custom LASIK Surgery Market was valued at US$ 1,537.6 million in 2016, as highlighted by Coherent Market Insights in its latest report on the market. High degree of precision and personalization as compared to conventional LASIK surgery is expected boost demand for custom LASIK surgery.
Custom LASIK surgery market has witnessed lucrative growth in last five years, owing to its added advantage over conventional LASIK surgery and advanced eye laser treatments. It offers high correction vision and also enhances quality of eye vision in terms of contrast sensitivity. Since the introduction of LASIK surgery in 1991, over 10 million patients have been benefitted worldwide. However, the personalized LASIK surgery gained traction post introduction of wavefront guided LASIK surgery in 2002. Since then, various companies have revolutionized the industry by venturing in custom LASIK surgery market.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187545

Increasing prevalence rate of refractive disorders, along with higher demand for eye laser treatment is expected to create market opportunity for players engaged in LASIK surgery market. For instance, over 23% of the U.S. population aged above 40 years suffered from myopia according to the American Academy of Ophthalmology 2016 estimates. There is high addressable market that needs to be capitalized upon. Only a fraction of the market is commercialized with custom LASIK surgery procedure. Existing leading companies are spend a considerable amount on development of custom LASIK technology. Companies such as Abbott Medical Optics, Alcon Laboratories, and Wavelight AG, have developed wavefront guided LASIK technology for individual treatment.
Key takeaways of the market are as follows:
• North America is estimated to account for nearly 38% of overall custom LASIK surgery market revenue in 2017. The market in this region is expected to be primarily driven by rising demand in the U.S. Presence of specialized refractive surgeons along with higher healthcare spending and awareness towards better treatment care is expected to bolster demand for custom LASIK surgery procedure in the region. In 2016, over 1,050 LASIK centers performed around 630,000 LASIK procedures in the U.S.
• The markets in Latin America and Asia Pacific is expected to register double digit growth rate over the forecast period. Rise in discretionary income along with increasing prevalence of refractive disorders are expected to create lucrative market opportunities for the players in these region. Though, Latin America custom LASIK surgery market size is expected to register relatively higher CAGR than Asia Pacific, the latter is expected to generate over 3.5 times of the revenue generated by Latin America by 2024 end.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187545

• While wavefront-guided procedure segment is expected to dominate the custom LASIK surgery market share throughout the forecast period, topography guided LASIK procedure segment is expected to register fastest CAGR between 2016 and 2024. Various companies are trying to establish their presence in the market through development and distribution of innovative products in the market. For instance, in 2015, Alcon—a subsidiary of Novartis—received FDA approval for topography guided LASIK procedure. Commercialization of the product is expected to drive revenue growth of the company over the forecast period.
• Abbott Medical Optics, Alcon Laboratories, Inc., Carl Zeiss, Inc., Bausch & Lomb, Nidek, Inc., and Technolas Perfect Vision GmbH are few of the key players in custom LASIK surgery market.
• Expansion of product portfolio along with the focus on long-term partnerships with LASIK centers are the prominent strategies adopted by leading players in this industry. For instance, Abbott received FDA approval for iDesign Advanced WaveScan Studio in 2015.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Laboratory Information Management Systems (LIMS) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Laboratory Information Management Systems Market (LIMS) was estimated at US$ 1,209.6 million in 2015 and is projected to reach US$ 2,271.5 million by 2024, according to a new report published by Coherent Market Insights. Increase in automation of processes in healthcare organizations is driving demand for LIMS worldwide.
Healthcare organizations are increasing spending on IT systems due to a shift towards utilization and maintenance of electronic health records (EHR). Usage of analytics techniques and big data is increasing among healthcare providers in order to improve their process outcomes and in turn make effective therapeutic decisions. Increasing trend of automating processes is pushing demand for customized solutions with multi-modality functions.
LIMS vendors are targeting different healthcare providers such as diagnostic laboratories, private clinics, blood banks, and other such institutes where use of LIMS is becoming a necessity for providing cost-effective services to their customers.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187537

Developed economies such as the U.S. and Western European countries are witnessing growing demand for technologically-advanced products, which can automate the healthcare process. Patients are becoming tech savvy and are using wearable devices connected with mobile healthcare applications in order to self-monitor their health. This has encouraged healthcare organizations and practitioners to transform their conventional operations by integrating the processes and patient's critical data.
LIMS is further expected to develop with the formation of a structured regulatory framework for healthcare IT, mainly in developed economies such as the U.S., Canada, and certain Western European nations. This would facilitate exchange of information between the clinicians and patients in a secured manner.
Key takeaways of the market:
• Demand for integrated systems is growing, with hospitals and clinical laboratories expanding their footprint by launching franchise chains. The integrated systems segment is projected to witness revenue growth at a CAGR of 7.2% during 2016 - 2024.
• Cloud-based systems provide a very cost-effective alternative to conventional systems used by healthcare providers. Market for cloud-based LIMS is expected to reach 339.8 million by 2024. Barriers with respect to security and compliance are gradually coming down leading to a growing demand for cloud-based scalable LIMS systems.
• As data analytics and big data are marking its way in the healthcare arena, the LIMS service segment is projected to expand at a CAGR of 8% during the forecast period. Data security and monitoring, customer relationship management, and patient engagement are services witnessing increasing traction from healthcare providers.
• Hospitals account for the largest market share of 49% (in terms of revenue) among end user segments in the market in 2015. The hospitals segment is expected to grow rapidly over the forecast period. Increasing patient database, organizational processes, and tests are propelling adoption of LIMS in hospitals.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187537

• Developed countries such as the U.S. and various Western European countries are the foremost adopters of this solution in order to reduce analytical work and improve efficiency. Due to this, North America held a lion's share of 56.4% (in terms of revenue) in 2015 in the global LIMS market. However, increasing number of healthcare facilities and rising expenditure on healthcare IT in emerging economies is anticipated to fuel demand for LIMS in these countries over the following decade.
Market leader such as Cerner Corporation, Merge Healthcare, Inc. (International Business Machines (IBM) Corp.), McKesson Corporation, LabWare, Roper Technologies Inc., and Meditech (Medical Information Technology, Inc.) are focusing on improving services and integrating new technologies in the current LIMS systems in order to enhance the efficiency of the systems, which in turn would help healthcare providers to offer better customer experience to payers.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Interventional Neurology Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Interventional Neurology Market is projected to reach USD 2,684.6 million by 2024, according to a new report by published by Coherent Market Insights. Recommendations from the American Heart Association and American Stroke Association to use neurointerventional devices in stroke is a major factor boosting market growth.
Increasing demand for minimally invasive procedures is one of the prime factors driving adoption of neurointerventional devices worldwide. The American Heart Association and American Stroke Association recommends use of neurointerventional devices in treating stroke, due to which there has been an augmented demand for these devices in the recent past. In order to capitalize on this highly lucrative growth opportunity, a range of new products such as Solitaire stent retriever, EmboTrap stent retriever, and Penumbra 3D Revascularization Device have been launched in the recent past.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187536

Developed economies such as the U.S., Canada, U.K., Australia, Japan, and Germany are witnessing rapid shift from conventional surgical methods to minimally invasive therapies. Moreover, there is a shift towards adopting detachable and bare platinum coils as against the highly priced coated coils. According to the Brain Aneurysm Foundation, around six million people in the U.S. i.e. one in 50 people suffer from brain aneurysm every year. High incidence rate of stroke and aneurysm is expected to continue strengthening demand for neurointerventional devices in the U.S. market.
The global Interventional neurology market is witnessing strategic agreements among leading players focusing on diversifying their product portfolio and increasing their market presence.
• In 2016, Codman & Shurtleff, Inc. inked an exclusive distribution agreement with InNeuroCo, Inc. for its intermediate catheter and super distal access device in the U.S. and European markets
• In 2015, Medtronic PLC acquired Lazarus Effect, a California-based medical device company engaged in development of acute ischemic stroke products for around US$ 100 million. Lazarus Effect was acquired with an aim to enhance Medtronic's neurovascular business and related portfolio.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187536

Advent of innovative solutions that enhance the outcomes of surgeries are fueling demand for neurointerventional devices
• Medical University of South Carolina (MUSC) is investigating the safety and success rate of ADAPT - direct-aspiration first pass technique that removes the clot in a single-pass
• FDA expanded the approval of Solitaire stent retriever device of Medtronic PLC for reduction of stroke-related disability. This device can now be used in patients with large vessel occlusion, proximal anterior circulation, and smaller core infarcts to reduce paralysis, and other stroke-related disabilities.
• CE approved EmboTrap stent retriever platform, the EmboTrap II Revascularization Device from Neuravi Ltd. This new device enables removal of clots of different lengths with ease.
Key takeaways of the market include:
• There are a range of neurointerventional devices such as embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices available in the market. Embolic coils was the largest segment and accounted for 32.5% share (in terms of revenue) in 2015. This is mainly due to these being the mainstay of endovascular treatment for brain aneurysms and hemorrhage.
• Demand for stent retrievers is anticipated to grow at a rapid pace during the forecast period (2016 - 2024). This is mainly attributed to these being used as a one-step technique for device deployment and clot retrieval. The launch of this device in Japan is anticipated to also contribute towards the market growth in Asia Pacific.
• Introduction of new techniques such as flow disruption and ADAPT aspiration technique is expected reduce the revenue share of coiling technique segment, and is projected to account 34.3% of the total market revenue by 2024
• Demand for neurointerventional devices is analyzed to be high in hospitals as compared to ambulatory centers, due to growing number of surgical procedures in hospitals. The hospitals end use segment is analyzed to expand at a CAGR of 5.2% during the forecast period.
• In 2015, North America dominated the global Interventional neurology market, with the contribution of the region estimated at US$ 701.9 million. Increasing incidence rate of brain aneurysm and ischemic strokes along with favorable government policies such as Medicare and Medicaid is expected to bolster sales of interventional neurology devices over the forecast period.
• Growing focus on introducing technological advanced devices is expected to drive market growth in the long run
• Stryker Corporation's subsidiary Concentric Medical's Trevo XP ProVue Retriever received FDA approval for its use in strokes in November 2016
• Penumbra 3D Revascularization Device Trial successfully met the primary trial endpoints in 2016.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Elderly and Disabled Assistive Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.

The Global Elderly and Disabled Assistive Devices Market was valued at US$ 14,109.1 million in 2015 and is projected to expand at a CAGR of 7.4% during the forecast period (2016-2024), according to a new report published by Coherent Market Insights. Rapidly aging population in Asia and Latin America is a major factor propelling demand for elderly and disabled assist devices.
Asia and Latin America are expected to witness rapid growth in population aged 65 years and above through 2030. The share of elderly population in Asia is expected to increase form 7.9% in 2015 to 12.1% in 2030, as per the report ‘An Aging World: 2015' by the U.S. Census Bureau. Also, increasing prevalence of chronic and acute diseases adds to the growing demand for technologically-advanced assistive devices for elderly and disabled population. Assistive devices such as wheelchairs, mobility scooters, walkers and rollators, and hearing and vision aids reduces dependence on others to carry out daily activities and improves quality of life of elderly and disabled patients.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187541

The World Health Organization (WHO) has prepared a comprehensive global disability action plan for 2014 - 2021. As per this plan, WHO intends to improve access to health services and programs, extend rehabilitation, assistive technology, assistance and support services, and support research on disability and related services. Assistive device manufacturers in the elderly and disabled assist devices market, especially in emerging economies are expected to benefit considerably through this plan.
Manufacturers in the elderly and disabled assist devices market are reaching out directly to consumers to increase their sales. Sonova Holding AG follows vertically-integrated business, wherein it also markets products through its retail stores, thus reaching out to customers and offering them customized solutions. The company acquired AudioNova in September 2016—a Netherlands-based hearing aid manufacturer—with an aim to double its presence in Europe in terms of retail stores.
Melvin ApS launched a robot called Melvin, which aids elderly and disabled people in the toilet. The robot was launched at the RoboBusiness Europe 2016 exhibition. Similarly, Vital Connect, Inc.is developing wearable health sensors that can detect body temperature, heart rate, detect falls and other such incidents in elderly and disabled patients. Such technological developments to increase individual independence and convenience is projected to lead to manifold growth of elderly and disabled assistive devices market in the near future.
Key takeaways of the market:
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187541

• The global elderly and disabled assist devices market is expected to expand at a CAGR of 7.4% during the forecast period. Increasing demand for elderly and disabled assist devices is mainly attributed to the factors such as convenience provided by automotive assistive devices to the growing elderly and disabled population
• Demand for vision and reading aids is analyzed to increase rapidly during the forecast period, owing to increasing incidence of vision impairment among the geriatric populace
• Hearing aids segment dominates the global elderly and disabled assist devices market (in terms of revenue) and is expected to reach US$ 7,083.5 million by 2017 end. Increasing market penetration, growing average discretionary income, and improved access to hearing aids is driving revenue growth of this segment. Furthermore, baby boomers population is expected to drive growth for hearing aids over the following decade, according to William Demant Holding Group.
• North America dominated the global elderly and disabled assist devices market in 2015. However, the market for elderly and disabled assistive devices in Asia Pacific is projected to expand significantly at a CAGR of 8.7% during the forecast period (2016-2024)
• Intense competition is witnessed among the leading players including Sunrise Medical LLC, GN ReSound Group, Sonova Holding AG, Starkey Hearing Technologies, and William Demant Holding A/S.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Global and Chinese Lease Administration Software Market ”to its Large Report database.

The 'Global and Chinese Lease Administration Software Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Lease Administration Software industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lease Administration Software manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/170111
Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Lease Administration Software industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/170111
The report then estimates 2018-2023 market development trends of Lease Administration Software industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Lease Administration Software Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 global and Chinese Lease Administration Software industry covering all important parameters.

Any special requirements about this report, please let us know and we can provide custom report.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Worldwide Market Reports added Latest Research Report titled “Global Ethyleneamines Market ”to its Large Report database.

Ethyleneamines are a class of amine compounds containing ethylene (-CH2CH2-) linkages between amine groups. These compounds are generally colorless, low-viscosity liquids with a fishy amine odor. The worldwide market for Ethyleneamines is expected to grow at a CAGR of roughly 0.9% over the next five years, will reach 1620 million US$ in 2023, from 1540 million US$ in 2017.
Scope of the Report:
This report focuses on the Ethyleneamines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In consumption market, the growth rate of global consumption is smooth. China and USA are still the mainly consumption regions due to the demand in the downstream and rapid development of economy.
Currently, There are two main routes for the production of ethyleneamines, the reaction between ethylene dichloride and ammonia. In the ethylene dichloride route, the initial product of this reaction is ethylenediamine. In the monoethanolamine route, monoethanolamine reacts with ammonia, catalyzed by transition metal catalysts.
We tend to believe this industry is a mature industry, and the consumption increasing degree will show a smooth growth curve. For product prices, the slow downward trend in recent years will maintain in the future as competition intensifies. Besides, prices gap between different brands will go narrowing gradually. Also, there will be fluctuation in gross margin.

Market Segment by Manufacturers, this report covers
Dow
AkzoNobel
Huntsman
BASF
Tosoh
Delamine
Shandong Lianmeng Chemical
Arabian Amines Company

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/197741

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
EDA
DETA
Piperazine
TETA
Other
Market Segment by Applications, can be divided into
Chelating Agents
Polyamide Resins
Fuel Additives
Surfactants
Others
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/197741

There are 15 Chapters to deeply display the global Ethyleneamines market.
Chapter 1, to describe Ethyleneamines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ethyleneamines, with sales, revenue, and price of Ethyleneamines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ethyleneamines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ethyleneamines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ethyleneamines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com